Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsing Forms of MS”

36 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 36 results

Large-scale testing (Phase 3)Study completedNCT02980042
What this trial is testing

Safety of Switching From Rituximab to Ocrelizumab in MS Patients

Who this might be right for
Multiple Sclerosis
University of Colorado, Denver 200
Not applicableEnded earlyNCT04746976
What this trial is testing

Study of Diroximel Fumarate in the Real-World Setting

Who this might be right for
Relapsing Forms of MS
Biogen 75
Post-approval studies (Phase 4)Study completedNCT00536120
What this trial is testing

The Effects of Tysabri Treatment on Vaccination Response and Lymphocyte Subsets in Subjects With Relapsing Forms of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Biogen 60
Large-scale testing (Phase 3)Study completedNCT00472797
What this trial is testing

Rebif New Formulation (RNF) Quality of Life (QOL) Study

Who this might be right for
Relapsing Multiple Sclerosis
EMD Serono 232
Post-approval studies (Phase 4)Active Not RecruitingNCT06444113
What this trial is testing

Concentration of Ofatumumab in the Breast Milk of Lactating Women With Relapsing Forms of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Novartis Pharmaceuticals 24
Not applicableStudy completedNCT01592097
What this trial is testing

Exploratory Study to Assess Clinical Response to Gilenya® (Fingolimod) in Hispanics With RRMS

Who this might be right for
Multiple Sclerosis
University of Southern California 51
Testing effectiveness (Phase 2)Ended earlyNCT01950234
What this trial is testing

ACTH in Progressive Forms of MS

Who this might be right for
Secondary Progressive Multiple SclerosisPrimary Progressive Multiple SclerosisProgressive Relapsing Multiple Sclerosis
University of Minnesota 59
Testing effectiveness (Phase 2)Ended earlyNCT00484536
What this trial is testing

Placebo Controlled Study in Subjects With Relapsing Forms of MS to Evaluate the Safety, Tolerability and Effects of CDP323

Who this might be right for
Multiple Sclerosis
UCB Pharma 232
Post-approval studies (Phase 4)Study completedNCT03784898
What this trial is testing

Collection of Blood Samples From Patients With Relapsing MS Who Developed ITP After Receiving Lemtrada

Who this might be right for
Multiple Sclerosis
Genzyme, a Sanofi Company 13
Post-approval studies (Phase 4)Study completedNCT03135249
What this trial is testing

Sequential Natalizumab - Alemtuzumab Therapy in Patients With Relapsing Forms of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis (MS)
University of Texas Southwestern Medical Center 9
Post-approval studies (Phase 4)Looking for participantsNCT07225361
What this trial is testing

Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis

Who this might be right for
Multiple SclerosisMultiple Sclerosis (MS) - Relapsing-remitting
Northwestern University 40
Post-approval studies (Phase 4)Ended earlyNCT02241785
What this trial is testing

Natalizumab as an Efficacy Switch in Participants With Relapsing Multiple Sclerosis After Failure on Other Therapies

Who this might be right for
Relapsing Multiple Sclerosis
Biogen 47
Testing effectiveness (Phase 2)Study completedNCT00109161
What this trial is testing

Study of Subcutaneous Daclizumab in Patients With Active, Relapsing Forms of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
PDL BioPharma, Inc. 270
Early research (Phase 1)Study completedNCT00813969
What this trial is testing

Autologous Mesenchymal Stem Cell (MSC) Transplantation in MS

Who this might be right for
Relapsing-Remitting Multiple SclerosisSecondary Progressive Multiple SclerosisProgressive Relapsing Multiple Sclerosis
The Cleveland Clinic 24
Large-scale testing (Phase 3)Study completedNCT01199861
What this trial is testing

Effect of Treatment With Fingolimod on the Immune Response Following Seasonal Flu Vaccination and Tetanus Booster Injection in Patients With Relapsing Multiple Sclerosis (MS)

Who this might be right for
Relapsing Multiple Sclerosis
Novartis 138
Large-scale testing (Phase 3)Study completedNCT01127750
What this trial is testing

Tolerability and Safety and Health Outcomes in Relapsing Multiple Sclerosis (MS) Patients

Who this might be right for
Relapsing Multiple Sclerosis
Novartis 2,417
Not applicableStudy completedNCT00464074
What this trial is testing

Evaluation of Natalizumab for thE Relief of MS Associated FatiGue

Who this might be right for
Multiple Sclerosis
Biogen 89
Not applicableStudy completedNCT01080014
What this trial is testing

Correlation Between Multiple Sclerosis Functional Composite (MSFC) and Expanded Disability Status Scale (EDSS) in Patients With Multiple Sclerosis (MS) in Argentina

Who this might be right for
Multiple Sclerosis
Merck KGaA, Darmstadt, Germany 252
Not applicableStudy completedNCT01070836
What this trial is testing

JC Virus Antibody Study of Participants With Relapsing Forms of MS Receiving Treatment With Natalizumab

Who this might be right for
Relapsing Multiple Sclerosis
Biogen 35,895
Not applicableActive Not RecruitingNCT05688436
What this trial is testing

Learn More About The Safety of Diroximel Fumarate (VUMERITY®) in Participants Who Took it During Pregnancy And About the Health of Their Babies

Who this might be right for
Multiple Sclerosis
Biogen 1,178
Next Page